Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The liver has numerous susceptible molecular therapeutic targets, making it possible to treat these diseases effectively by modulating these targets with novel therapeutic oligonucleotides.
Therapeutic oligonucleotides represent a significant advancement in the treatment of metabolic liver diseases, offering targeted and effective solutions. However, ongoing research and careful monitoring are essential to address safety concerns and fully realize their potential.
References:
…